Behrenbruch Christian - 28 Apr 2026 Form 4 Insider Report for Telix Pharmaceuticals Ltd (TLX)

Reporting relationship: MD & Group CEO, Director
Issuer ticker: TLX
Reported as of: 28 Apr 2026
Net transaction value: +$996,738
SEC form: 4
Accepted by SEC: 06 May 2026, 21:32:08 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Oliver Newman, on behalf of Dr. Christian Behrenbruch, MD & Group CEO

Key filing fact

Behrenbruch Christian filed Form 4 for Telix Pharmaceuticals Ltd (TLX) on 06 May 2026.

Key facts

This page summarizes Behrenbruch Christian's Form 4 filing for Telix Pharmaceuticals Ltd (TLX).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 06 May 2026, 21:32.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: +$996,738.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002037713 Primary reporting owner

Behrenbruch Christian

Relationship: MD & Group CEO, Director
Address: C/O TELIX PHARMACEUTICALS LTD, 55 FLEMINGTON RD, NORTH MELBOURNE, AUSTRALIA
Signature: /s/ Oliver Newman, on behalf of Dr. Christian Behrenbruch, MD & Group CEO
Signature date: 06 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TLX transaction

Ordinary Shares

Purchase

Transaction value: $499,560
Shares: +34,500
Change %: +0.17%
Price: $14.48
Shares after: 20,709,500
Date: 28 Apr 2026
Ownership: Elk River Holdings Pty Ltd
Footnotes: F1, F2, F3

TLX transaction

Ordinary Shares

Purchase

Transaction value: $497,178
Shares: +33,435
Change %: +0.16%
Price: $14.87
Shares after: 20,742,935
Date: 29 Apr 2026
Ownership: Elk River Holdings Pty Ltd
Footnotes: F2, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The price reported in Column 4 is an average price. The shares were purchased in multiple transactions at prices ranging from $14.42 - $14.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (SEC), upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

Footnote F2

The purchase prices are reported in Australian Dollars.

Footnote F3

Dr. Behrenbruch is the sole director and shareholder of Elk River Holdings Pty Ltd.

Footnote F4

The price reported in Column 4 is an average price. The shares were purchased in multiple transactions at prices ranging from $14.54 - $14.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (4) to this Form 4.